Ledger.Open graph →
SEC Form D · filed January 5, 2011

EYEGATE PHARMACEUTICALS INC

Offering
$4.5M
Sold
$4.5M
Exemption
—
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

People & firms on this filing (15)

Thomas E. Hancock · Quincy, MADirectorPaul Chaney · Melville, NYDirectorMorton Goldberg · Waltham, MADirectorPraveen Tyle · Waltham, MADirectorAlain Maiore · Paris, I0DirectorStephen From · Waltham, MAExec · DirectorFranklin Advisers, Inc · SAN MATEO, CAExec · DirectorGregory E. Mcgowan · FORT LAUDERDALE, FLDirectorJohn M. Lusk · SAN MATEO, CADirectorKent P. Strazza · SAN MATEO, CADirectorEric S. Fenster · Kensington, CADirectorMarc Franzman · Milford, CTDirectorWalter Meier · Waltham, MADirectorLaurent Assaraf · Paris, I0DirectorMichael Patane · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗